French pharmaceutical company Sanofi has established a new innovation and operations facility in Chengdu, China. The center will focus on research and development, clinical trials, and manufacturing support for the company's operations.
French pharmaceutical giant Sanofi has established a new innovation and operations facility in Chengdu, a major city in southwestern China, according to a company announcement made Friday through its Chinese social media channels.
The newly opened center, which began operations Thursday, is designed to enhance Sanofi’s research and development capabilities while also supporting clinical trial operations and strengthening manufacturing and supply chain services throughout the region.
The facility represents Sanofi’s continued expansion into Asian markets as the company seeks to bolster its global pharmaceutical operations and research initiatives.
VP Vance Planning Hungary Visit Ahead of Orbán’s Crucial Election
NY Federal Prosecutors Investigating Colombian President for Drug Cartel Links
Georgia Becomes First State to Suspend Gas Tax as Prices Surge
McCormick’s Strategic Acquisitions Lead to Potential $30B Unilever Food Deal